• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria.

作者信息

Sánchez-Borges Mario, Ansotegui Ignacio, Jimenez Jorge Montero, Rojo Maria Isabel, Serrano Carlos, Yañez Anahí

机构信息

Allergy and Clinical Immunology Department, Centro Médico-Docente la, Trinidad and Clínica El Avila, 6a transversal Urb. Altamira, piso 8, consultorio 803, Caracas, 1060 Venezuela.

Department of Allergy and Immunology, Hospital Quirón Bizkaia, Erandio, Spain.

出版信息

World Allergy Organ J. 2014 Nov 26;7(1):33. doi: 10.1186/1939-4551-7-33. eCollection 2014.

DOI:10.1186/1939-4551-7-33
PMID:25829981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4363057/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8e/4363057/d000be5e19e8/40413_2014_73_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8e/4363057/d000be5e19e8/40413_2014_73_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8e/4363057/d000be5e19e8/40413_2014_73_Fig1_HTML.jpg

相似文献

1
Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria.非镇静性抗组胺药增量给药对慢性荨麻疹患者的疗效比较
World Allergy Organ J. 2014 Nov 26;7(1):33. doi: 10.1186/1939-4551-7-33. eCollection 2014.
2
Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria.第二代非镇静性 H1 抗组胺药在慢性自发性荨麻疹儿童中增加剂量的疗效和耐受性。
Pediatr Allergy Immunol. 2021 Jan;32(1):153-160. doi: 10.1111/pai.13325. Epub 2020 Aug 26.
3
Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis.慢性自发性荨麻疹患者非镇静性抗组胺药加量治疗：系统评价和荟萃分析。
Br J Dermatol. 2016 Dec;175(6):1153-1165. doi: 10.1111/bjd.14768. Epub 2016 Oct 19.
4
Antihistamines in urticaria and angioedema.荨麻疹和血管性水肿中的抗组胺药。
Clin Allergy Immunol. 2002;17:249-86.
5
Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.荨麻疹和血管性水肿的治疗：低镇静作用的H1型抗组胺药。
J Am Acad Dermatol. 1991 Jun;24(6 Pt 2):1084-7. doi: 10.1016/0190-9622(91)70161-t.
6
Bilastine: a new H -antihistamine with an optimal profile for updosing in urticaria.比拉斯汀：一种新型 H1 抗组胺药，在荨麻疹的加量治疗中有最佳的特征。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1447-1452. doi: 10.1111/jdv.14305. Epub 2017 Jun 1.
7
Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.用高于标准剂量的第二代非镇静抗组胺药治疗慢性荨麻疹的药理学原理。
J Eur Acad Dermatol Venereol. 2012 Jan;26(1):9-18. doi: 10.1111/j.1468-3083.2011.04185.x. Epub 2011 Jul 29.
8
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.奥马珠单抗剂量递增治疗慢性自发性荨麻疹：真实世界证据概述。
Clin Rev Allergy Immunol. 2020 Aug;59(1):38-45. doi: 10.1007/s12016-020-08794-6.
9
Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?以非镇静抗组胺药治疗难治性慢性荨麻疹：是否有增加剂量的证据？
J Investig Allergol Clin Immunol. 2013;23(3):141-4; quiz 2 p preceding 145.
10
Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.基于组胺诱导风团的初始抑制预测抗组胺药治疗慢性自发性荨麻疹的疗效。
J Investig Allergol Clin Immunol. 2016;26(3):177-84. doi: 10.18176/jiaci.0039.

引用本文的文献

1
Allergic rhinitis and urticaria burden and antihistamine treatment options in Thailand: A modified Delphi study.泰国变应性鼻炎和荨麻疹的负担及抗组胺药治疗选择：一项改良德尔菲研究。
J Allergy Clin Immunol Glob. 2025 Feb 19;4(2):100444. doi: 10.1016/j.jacig.2025.100444. eCollection 2025 May.
2
Clinical efficacy of Zhiyang Xiaozhen granules combined with second-generation antihistamine in the treatment of chronic urticaria.止痒消疹颗粒联合第二代抗组胺药治疗慢性荨麻疹的临床疗效。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):175-181. doi: 10.11817/j.issn.1672-7347.2024.230381.
3
Present and future: Infectious tropical travel rashes and the impact of climate change.

本文引用的文献

1
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.变应性接触性皮炎诊断和治疗的欧洲指南（2013 年版）
Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30.
2
Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use.难治性慢性荨麻疹的替代药物：选择和使用的证据和考虑因素。
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):433-440.e1. doi: 10.1016/j.jaip.2013.06.003. Epub 2013 Aug 2.
3
Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?
现状与未来：传染性热带旅行皮疹与气候变化的影响。
Ann Allergy Asthma Immunol. 2023 Apr;130(4):452-462. doi: 10.1016/j.anai.2022.12.025. Epub 2022 Dec 24.
4
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria.一项比较性、三臂、随机临床试验，旨在评估在慢性自发性荨麻疹患者中，标准剂量的比拉斯汀与非索非那定、左西替利嗪的有效性和耐受性，以及高剂量（增量给药）的比拉斯汀与非索非那定、左西替利嗪及羟嗪（联合用药）的有效性和耐受性。
Clin Cosmet Investig Dermatol. 2022 Feb 18;15:261-270. doi: 10.2147/CCID.S350122. eCollection 2022.
5
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.慢性荨麻疹的挑战 第2部分：药物治疗、慢性诱导性荨麻疹、特殊情况下的荨麻疹
World Allergy Organ J. 2021 Jun 3;14(6):100546. doi: 10.1016/j.waojou.2021.100546. eCollection 2021 Jun.
6
Balanced discussion of second-generation antihistamines' data.第二代抗组胺药数据的均衡讨论。
Ther Clin Risk Manag. 2016 Nov 24;12:1777-1781. doi: 10.2147/TCRM.S124148. eCollection 2016.
7
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria.比拉斯汀、左西替利嗪和地氯雷他定递增剂量治疗慢性荨麻疹的疗效比较
Ther Clin Risk Manag. 2016 Nov 25;12:1793-1796. doi: 10.2147/TCRM.S120628. eCollection 2016.
8
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.过敏性鼻炎和荨麻疹的治疗：新型抗组胺药物比拉斯汀综述
Ther Clin Risk Manag. 2016 Apr 13;12:585-97. doi: 10.2147/TCRM.S105189. eCollection 2016.
以非镇静抗组胺药治疗难治性慢性荨麻疹：是否有增加剂量的证据？
J Investig Allergol Clin Immunol. 2013;23(3):141-4; quiz 2 p preceding 145.
4
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.加倍剂量的比拉斯汀可改善冷接触性荨麻疹的疗效。
Allergy. 2013 Jul;68(7):921-8. doi: 10.1111/all.12171. Epub 2013 Jun 6.
5
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.荨麻疹和血管性水肿的诊断和治疗：全球视角。
World Allergy Organ J. 2012 Nov;5(11):125-47. doi: 10.1097/WOX.0b013e3182758d6c.
6
Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine.117 例常规剂量抗组胺药物治疗未控制的慢性自发性荨麻疹患者的预后。
Allergy. 2013 Feb;68(2):229-35. doi: 10.1111/all.12078. Epub 2012 Dec 4.
7
Treatment of chronic spontaneous urticaria.慢性自发性荨麻疹的治疗。
Allergy Asthma Immunol Res. 2012 Nov;4(6):326-31. doi: 10.4168/aair.2012.4.6.326. Epub 2012 May 14.
8
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?H(1)-抗组胺药和荨麻疹：我们如何为患者预测最佳药物？
Clin Exp Allergy. 2012 Oct;42(10):1423-9. doi: 10.1111/j.1365-2222.2012.03957.x.
9
Ebastine in chronic spontaneous urticaria in higher doses.高剂量依巴斯汀治疗慢性自发性荨麻疹
Indian J Dermatol. 2011 Sep-Oct;56(5):597-8. doi: 10.4103/0019-5154.87168.
10
Histamine and H1-antihistamines: celebrating a century of progress.组胺和 H1 抗组胺药：百年发展成就回顾。
J Allergy Clin Immunol. 2011 Dec;128(6):1139-1150.e4. doi: 10.1016/j.jaci.2011.09.005. Epub 2011 Oct 27.